Skip to main content

Advertisement

Open Peer Review Reports for: SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
24 Mar 2018 Submitted Original manuscript
29 Apr 2018 Author responded Author comments - Soo Young Kim
Resubmission - Version 2
29 Apr 2018 Submitted Manuscript version 2
14 May 2018 Reviewed Reviewer Report - Hsiang-Fong Kao
29 May 2018 Reviewed Reviewer Report - Tai-Jan Chiu
26 Jul 2018 Author responded Author comments - Soo Young Kim
Resubmission - Version 3
26 Jul 2018 Submitted Manuscript version 3
31 Jul 2018 Reviewed Reviewer Report - Hsiang-Fong Kao
6 Sep 2018 Reviewed Reviewer Report - Tai-Jan Chiu
19 Sep 2018 Author responded Author comments - Soo Young Kim
Resubmission - Version 4
19 Sep 2018 Submitted Manuscript version 4
Publishing
24 Sep 2018 Editorially accepted
4 Oct 2018 Article published 10.1186/s12885-018-4854-z

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement